Donald Rumsfeld..
Sec of Defense 1975-1977 and again 2001 -2006.
President of Searle Pharmaceuticals 1977-1985
CEO General Instrument 1990 - 1993
Chairman Gilead Sciences 1997 - 2001..

I'm seeing a Big Pharma background mixed in with the War machine. And let's not ever forgot his hand in Aspartame ..:-)

Lynda

***********************************

Snip

By

GreatGameIndia -
April 10, 2020

Gilead Sciences is an American biotechnology company holding the patent for the drug Remdesivir for treating various Coronavirus cases in over 70 countries. The company has secured orphan drug status for Remdesivir, allowing it to exclusively obtain marketing revenues for up to 7 years. However, behind the benign image of a vaccine manufacturer, Gilead Science has a dark history of allegations of bioterrorism, including having the Pentagon bomb a competitors' factory under the false pretext of association with Al-Qaeda.

**************
Bombing a rival factory in Sudan

Former U.S. Secretary of Defence, Donald Rumsfeld was once the Managing Director of Gilead Sciences. It was an “amazing coincidence” that the drug Tamiflu patented by Gilead Sciences was pushed by the National Institutes of Allergies and Infectious Diseases as its top choice of drug to combat flu, while Rumsfeld, around 2004, held a stake in Gilead Sciences worth $5 million to $25 million. Tamiflu was reportedly expected to remain in short supply for as long as a year just as the purchase of $2 billion doses of the drug by the U.S. government got underway using scare tactics.

Donald Rumsfeld’s profiteering with Gilead extends into the area of warfare as well. In 1997, he initiated research on bioterrorism with work on a molecule called Cidofovir, which was traditionally used in the treatment of smallpox. In 1998, Donald Rumsfeld convinced Bill Clinton to bomb a factory of Al-Shifa, a rival and competitor of Gilead in Sudan, under the pretext that the Company was manufacturing chemical weapons for Al-Qaeda.
Fake Pandemic, Real Profits

Gilead’s flu drug, Tamiflu, originally manufactured by Gilead Sciences, was criticized for being ineffective and even harmful. Chairman of Gilead Sciences Donald Rumsfeld and Board Member of Gilead, Former U.S. Secretary of State, George Schultz profited heavily from a $1.5 billion stockpiling by the U.S. government on Tamiflu leading up to the 2009 H1N1 “swine flu” outbreak.

The interesting part is, Gilead was part of the vaccine lobby at whose behest the WHO faked the H1N1 pandemic in 2009, and kept it a secret from people until committees were set up which exposed the entire racket.

In March 2014, the US FDA approved a daily pill that could cure the most common form of hepatitis C for a whopping $1,125-per-pill price. The Harvoni combination pill was targeted at patients with the liver-destroying virus that accounted for 70% of the estimated 3.2 million cases in the U.S.

Harvoni was hardly the first “blockbuster” Gilead had. Its Sovaldi drug plus a cocktail of two other drugs cost close to $95,000 for 12 weeks, on average, per the Company.
Remdesivir – The Coronavirus Drug

Gilead holds exclusive patents for the drug Remdesivir in over 70 countries. In March 2020, Gilead fought to maintain its patent on remdesivir as a treatment for several coronaviruses, initiating legal conflicts with the Wuhan Institute of Virology, from where it is believed COVID-19 was weaponized and leaked.

Soon after Gilead received approval as an “Orphan drug” by the U.S. Food and Drug Administration (FDA) on March 24th, 2020. The orphan drug label implies tremendous tax benefits, government funding support, exclusivity and price control for the drug manufacturer. According to Bank of America analysts quoted in the U.S. press, Gilead could pocket up to $2.5 billion thanks to its anti-viral drug.